Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02697721 · ClinicalTrials.gov registry record · NA

Powerful Tools for Caregivers of Dementia Patients

A NA study of Alzheimer Disease and Dementia, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT02697721: Completed NA study of Alzheimer Disease and Dementia, sponsored by Florida State University.

NCT02697721 is a NA study of Alzheimer Disease and Dementia that has completed, run by Florida State University. The registered enrollment target is 60 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02697721, a NA study of Alzheimer Disease and Dementia, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine if a psycho-educational intervention for caregivers of patients with dementia will decrease caregiver burden, increase caregiver physical activity, and decrease the reporting of behavioral and psychological symptoms of the person with dementia.

Primary Outcome

Zarit Caregiver Burden Scale scores

Interventions

  • BEHAVIORAL Powerful Tools for Caregivers
  • OTHER Control with delayed intervention

Study Locations (1)

Florida

  • Florida State University College of Medicine - Tallahassee

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2016-02
Est. Completion 2019-02
Phase NA
Florida State University

219 total trials

What the finished NCT02697721 record still lists

NCT02697721 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Powerful Tools for Caregivers is the first listed.

NCT02697721 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT02697721 about?

NCT02697721 is a clinical study titled "Powerful Tools for Caregivers of Dementia Patients". The purpose of this study is to examine if a psycho-educational intervention for caregivers of patients with dementia will decrease caregiver burden, increase caregiver physical activity, and decrease the reporting of behavioral and psychological symptoms of the person with dementia.

What is the current status of trial NCT02697721?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-02. Estimated completion is 2019-02.

What conditions does trial NCT02697721 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Caregivers.

What interventions are being tested in trial NCT02697721?

The interventions under investigation include: Powerful Tools for Caregivers (BEHAVIORAL), Control with delayed intervention (OTHER).

Who is sponsoring clinical trial NCT02697721?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02697721 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02697721's enrollment target sits among peer trials

60 187th of 306 higher than 108 of 306 other Alzheimer Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02697721, the US trial registry maintained by the National Library of Medicine. NCT02697721 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.